BTAI BioXcel Therapeutics Inc

USD 1.21 0.00 0
Icon

BioXcel Therapeutics Inc (BTAI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.21

0.00 (0.00)%

USD 0.05B

0.43M

USD 8.14(+572.96%)

USD 20.00 (+1552.89%)

Icon

BTAI

BioXcel Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.21
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.05B

USD 20.00 (+1552.89%)

USD 1.21

BioXcel Therapeutics Inc (BTAI) Stock Forecast

Show ratings and price targets of :
USD 8.14
(+572.96%)

Based on the BioXcel Therapeutics Inc stock forecast from 4 analysts, the average analyst target price for BioXcel Therapeutics Inc is USD 8.14 over the next 12 months. BioXcel Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of BioXcel Therapeutics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, BioXcel Therapeutics Inc’s stock price was USD 1.21. BioXcel Therapeutics Inc’s stock price has changed by +15.24% over the past week, -11.68% over the past month and -88.25% over the last year.

No recent analyst target price found for BioXcel Therapeutics Inc
No recent average analyst rating found for BioXcel Therapeutics Inc

Company Overview BioXcel Therapeutics Inc

BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs a...Read More

555 Long Wharf Drive, New Haven, CT, United States, 06511

74

December

USD

USA

Adjusted Closing Price for BioXcel Therapeutics Inc (BTAI)

Loading...

Unadjusted Closing Price for BioXcel Therapeutics Inc (BTAI)

Loading...

Share Trading Volume for BioXcel Therapeutics Inc Shares

Loading...

Compare Performance of BioXcel Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BTAI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BioXcel Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing BTAI

Symbol Name BTAI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BioXcel Therapeutics Inc (BTAI) Stock

Based on ratings from 4 analysts BioXcel Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on BTAI's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for BTAI is USD 8.14 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 4.

Unfortunately we do not have enough data on BTAI's stock to indicate if its overvalued.

The last closing price of BTAI's stock was USD 1.21.

The most recent market capitalization for BTAI is USD 0.05B.

Based on targets from 4 analysts, the average taret price for BTAI is projected at USD 8.14 over the next 12 months. This means that BTAI's stock price may go up by +572.96% over the next 12 months.

We can't find any ETFs which contains BioXcel Therapeutics Inc's stock.

As per our most recent records BioXcel Therapeutics Inc has 74 Employees.

BioXcel Therapeutics Inc's registered address is 555 Long Wharf Drive, New Haven, CT, United States, 06511. You can get more information about it from BioXcel Therapeutics Inc's website at https://www.bioxceltherapeutics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...